Oncopharmpod

In the 1st of the Landmarks series, we look back at a pivotal article published in Blood in 1958 on the treatment of acute leukemia.

2017 saw A LOT of #oncopharm approvals. Oncology pharmacist & educator John Bossaer runs through some of the most notable oncology pharmacy trends of the year, include CAR-T cell therapy

Discussion of gefitinib's journey back to the market and lessons to be learned from it by oncology pharmacist & educator John Bossaer.

Recent FDA updates & a brief discussion about adjuvant TKI use in solid tumors.

Oncology Pharmacy Podcast discussing the FDA-approval of acalabrutinib